Literature DB >> 15690381

Delineation of an interstitial 9q22 deletion in basal cell nevus syndrome.

S E Boonen1, D Stahl, S Kreiborg, T Rosenberg, V Kalscheuer, L A Larsen, N Tommerup, K Brøndum-Nielsen, Z Tümer.   

Abstract

Basal cell nevus syndrome (Gorlin syndrome) is an autosomal dominant disorder characterized by the presence of multiple basal cell carcinomas (BCC), odontogenic keratocysts, palmoplantar pits, and calcification in the falx cerebri caused by mutational inactivation of the PTCH gene. In few cases, the syndrome is due to a microdeletion at 9q22. Using high-resolution chromosome analysis we have identified a patient with the karyotype, 46,XY,del(9)(q21.3q31) de novo. He had typical clinical features consistent with basal cell nevus syndrome, but also additional features likely to be caused by loss of additional chromosomal material in this region. The deletion breakpoints were characterized with fluorescence in situ hybridization (FISH) analysis using BAC clones. The 15 Mb long deletion includes 87 RefSeq genes including PTCH. Hemizygosity of one or more genes might contribute to the additional symptoms observed in this patient. (c) 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2005        PMID: 15690381     DOI: 10.1002/ajmg.a.30422

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  13 in total

Review 1.  Emerging treatments and gene expression profiling in high-risk medulloblastoma.

Authors:  Iacopo Sardi; Duccio Cavalieri; Maura Massimino
Journal:  Paediatr Drugs       Date:  2007       Impact factor: 3.022

2.  9q22 Deletion--first familial case.

Authors:  Linda Siggberg; Maarit Peippo; Marjatta Sipponen; Taina Miikkulainen; Keiko Shimojima; Toshiyuki Yamamoto; Jaakko Ignatius; Sakari Knuutila
Journal:  Orphanet J Rare Dis       Date:  2011-06-22       Impact factor: 4.123

3.  [Hereditary head and neck tumors].

Authors:  S Schwarz-Furlan; C Brase; P Stockmann; I Furlan; A Hartmann
Journal:  Pathologe       Date:  2010-10       Impact factor: 1.011

Review 4.  Nevoid basal cell carcinoma syndrome (Gorlin syndrome).

Authors:  Lorenzo Lo Muzio
Journal:  Orphanet J Rare Dis       Date:  2008-11-25       Impact factor: 4.123

5.  Dynamic Hedgehog signalling pathway activity in germline stem cells.

Authors:  Z Sahin; A Szczepny; E A McLaughlin; M L Meistrich; W Zhou; I Ustunel; K L Loveland
Journal:  Andrology       Date:  2014-03       Impact factor: 3.842

6.  High-density oligonucleotide array with sub-kilobase resolution reveals breakpoint information of submicroscopic deletions in nevoid basal cell carcinoma syndrome.

Authors:  Katsunori Fujii; Shumpei Ishikawa; Hideki Uchikawa; Daisuke Komura; Michael H Shapero; Fan Shen; Jing Hung; Hiroshi Arai; Yoko Tanaka; Kimio Sasaki; Yoichi Kohno; Masao Yamada; Keith W Jones; Hiroyuki Aburatani; Toshiyuki Miyashita
Journal:  Hum Genet       Date:  2007-08-17       Impact factor: 4.132

Review 7.  Novel microdeletion syndromes detected by chromosome microarrays.

Authors:  Anne M Slavotinek
Journal:  Hum Genet       Date:  2008-05-30       Impact factor: 4.132

8.  Copy number variation analysis in single-suture craniosynostosis: multiple rare variants including RUNX2 duplication in two cousins with metopic craniosynostosis.

Authors:  Heather C Mefford; Neil Shafer; Francesca Antonacci; Jesse M Tsai; Sarah S Park; Anne V Hing; Mark J Rieder; Matthew D Smyth; Matthew L Speltz; Evan E Eichler; Michael L Cunningham
Journal:  Am J Med Genet A       Date:  2010-09       Impact factor: 2.802

9.  PTCH mutations and deletions in patients with typical nevoid basal cell carcinoma syndrome and in patients with a suspected genetic predisposition to basal cell carcinoma: a French study.

Authors:  N Soufir; B Gerard; M Portela; A Brice; M Liboutet; P Saiag; V Descamps; D Kerob; P Wolkenstein; I Gorin; C Lebbe; N Dupin; B Crickx; N Basset-Seguin; B Grandchamp
Journal:  Br J Cancer       Date:  2006-08-21       Impact factor: 7.640

10.  Microdeletion of 9q22.3: A patient with minimal deletion size associated with a severe phenotype.

Authors:  Adam D Ewing; Seth W Cheetham; James J McGill; Michael Sharkey; Rick Walker; Jennifer A West; Malcolm J West; Kim M Summers
Journal:  Am J Med Genet A       Date:  2021-05-07       Impact factor: 2.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.